Multidisciplinary Clinical Care in the Management of Patients Receiving Anti-GD2 Immunotherapy for High-Risk Neuroblastoma.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 13, doi. 10.1007/s40272-022-00544-9
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2023 AND VI 25 AND IP 1
Results: 11
1
2
Acknowledgement to Referees.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 1, doi. 10.1007/s40272-022-00552-9
- Publication type:
- Article
3
Interventions for the Management of Pain and Sedation in Newborns Undergoing Therapeutic Hypothermia for Hypoxic-Ischemic Encephalopathy: A Systematic Review.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 27, doi. 10.1007/s40272-022-00546-7
- By:
- Publication type:
- Article
4
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 43, doi. 10.1007/s40272-022-00545-8
- By:
- Publication type:
- Article
5
Ibrutinib: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 127, doi. 10.1007/s40272-022-00543-w
- By:
- Publication type:
- Article
6
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 67, doi. 10.1007/s40272-022-00553-8
- By:
- Publication type:
- Article
7
Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 87, doi. 10.1007/s40272-022-00542-x
- By:
- Publication type:
- Article
8
Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 79, doi. 10.1007/s40272-022-00541-y
- By:
- Publication type:
- Article
9
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 115, doi. 10.1007/s40272-022-00536-9
- By:
- Publication type:
- Article
10
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 5, doi. 10.1007/s40272-022-00535-w
- By:
- Publication type:
- Article
11
Trends in Adverse Drug Reactions Among Children: Evidence from Jiangsu Province of China, 2010–2019.
- Published in:
- Pediatric Drugs, 2023, v. 25, n. 1, p. 97, doi. 10.1007/s40272-022-00539-6
- By:
- Publication type:
- Article